News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Mar 26, 2012

Mar 26, 2012

Fouchier anticipates resuming H5N1 studies soon

(CIDRAP News) – The lead researcher of one of the controversial H5N1 avian influenza transmission studies in ferrets said today that he hopes scientists can resume work on the studies in about 2 weeks, after key groups have discussed the issues.

Jun 21, 2012

Jun 21, 2012

Fouchier study reveals changes enabling airborne spread of H5N1

(CIDRAP News) – A study showing that it takes as few as five mutations to turn the H5N1 avian influenza virus into an airborne spreader in mammals—and that launched a historic debate on scientific accountability and transparency—was released today in Science, spilling the full experimental details that many experts had sought to suppress out of concern that publishing them could lead to the unleashing of a dangerous virus.

Apr 05, 2013

Apr 05, 2013

China confirms H7N9 in poultry, more human cases

(CIDRAP News) – Chinese agriculture officials today confirmed the H7N9 virus in chickens and pigeons from Shanghai markets, providing new clues about how humans may have been exposed to the virus, which has since yesterday been detected in two more people.

May 03, 2013

Sep 15, 2014

Sep 15, 2014

News Scan for Sep 15, 2014

Chikungunya spike
More EV-D68 cases
Additional MERS case
CDC animal-related safety breach
Poliovirus spill in Belgium

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»